DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	264,852	191,632	164,306	164,657	163,255	269,902
Market Cap Growth	27.81%	16.63%	-0.21%	0.86%	-39.51%	21.16%
Enterprise Value	362,192	288,813	265,142	243,200	219,445	325,800
Last Close Price	15120.00	10838.56	9161.15	9028.01	8795.54	14370.29
PE Ratio	6666.89	360.61	-	147.59	73.63	-
PS Ratio	1.77	1.28	1.16	1.25	1.39	2.47
PB Ratio	3.59	2.51	2.12	2.02	1.96	3.13
P/TBV Ratio	6.77	4.49	3.67	3.27	2.96	4.49
P/FCF Ratio	135.85	218.93	-	-	232.62	-
P/OCF Ratio	51.77	36.50	-	20.10	15.72	101.72
EV/Sales Ratio	2.42	1.93	1.88	1.84	1.87	2.98
EV/EBITDA Ratio	30.26	22.02	33.85	23.41	27.08	33.90
EV/EBIT Ratio	61.46	43.03	135.12	41.60	66.82	82.64
EV/FCF Ratio	185.78	329.96	-	-	312.68	-
Debt / Equity Ratio	1.36	1.30	1.43	1.10	0.84	0.74
Debt / EBITDA Ratio	8.38	7.57	14.11	8.67	8.66	6.61
Debt / FCF Ratio	51.48	113.42	-	-	99.96	-
Asset Turnover	0.71	0.70	0.68	0.70	0.67	0.64
Inventory Turnover	3.04	3.35	3.86	4.10	3.85	3.63
Quick Ratio	0.26	0.25	0.29	0.33	0.49	0.39
Current Ratio	0.53	0.52	0.51	0.62	0.75	0.66
Return on Equity (ROE)	0.52%	1.08%	-0.65%	1.48%	2.31%	-2.92%
Return on Assets (ROA)	1.74%	1.97%	0.59%	1.94%	1.17%	1.44%
Return on Invested Capital (ROIC)	0.93%	2.15%	1.16%	1.97%	1.04%	3.02%
Return on Capital Employed (ROCE)	6.90%	7.60%	2.20%	5.00%	3.20%	4.00%
Earnings Yield	0.01%	0.28%	-0.70%	0.68%	1.36%	-0.74%
FCF Yield	0.74%	0.46%	-5.55%	-11.84%	0.43%	-0.41%
Dividend Yield	0.99%	1.38%	1.64%	1.66%	-	-
Payout Ratio	6613.98%	494.43%	-	235.51%	118.28%	-
Buyback Yield / Dilution	0.06%	-	-	-0.33%	-0.87%	1.48%
Total Shareholder Return	1.05%	1.38%	1.64%	1.34%	-0.87%	1.48%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.